The loss of a #loop. Recognising the “Life” benefits of hybrid closed loop systems.
A day without a loop – it feels like an eternity. As crazy as it seems. But why? Well let’s start at the beginning, and […]
Blog Posts
Looping – getting started with dosing decision making apps (or Artificial Pancreases)
I recently had a conversation with someone who was struggling to manage their lows. They lacked hypoglycaemic awareness and found themselves regularly lower than they […]
Catching up with Medtrum. Where are they since the JDRF Discovery Day?
This evening I had the opportunity to meet up with the team from Medtrum that is currently working their way around the UK and Europe, […]
Hybrid Closed Looping with @OpenAPS and #Loop – a psychological perspective #wearenotwaiting
As I’ve been looping now for a little bit, I thought it was worthwhile to share one aspect of the experience that’s perhaps not so […]
How closed loops and faster, liver directed insulins will change your life #wearenotwaiting
Imagine, if you will, that those who struggle with their diabetes need only minimal self-intervention to maintain DCTT recommended Hba1C levels and excellent glycaemic variability. […]
@openAPS – more steps forward… Does it ever stand still? Not if #wearenotwaiting
When I wrote about using OpenAPS last time around, I had a list of features that I was having a few issues with. Since then […]
If you’re in the US, is the Medtronic 630G really worth it?
If you take a look at the Facebook page for the Medtronic 640G, you’d be forgiven for thinking that the US has something similar available, […]
@OpenAPS – Standing on the shoulders of giants – #wearenotwaiting for an artificial pancreas!
loop /luːp/ verb 1. To monitor realtime glucose values and makes decisions to administer insulin accordingly. As I mentioned previously, I’d spent a fair amount […]
Comparing @OpenAPS and the Medtronic Hybrid Closed Loop System – what does the data say?
With the release yesterday of the Medtronic Hybrid Closed Loop pivotal study data, I thought it would be interesting to take a look at the […]
The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]